Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.4B | $2B | $2B | $479.8M | $338M | |
| Gross Profit | $225M | $453.8M | $563M | $117.4M | $41.6M | |
| Operating Income | $212.3M | $365.2M | $473.5M | $106.2M | $4.4M | |
| EBITDA | $572.3M | $803.8M | $894.9M | $206.9M | $90.3M | |
| Diluted EPS | $0.03 | $0.23 | $1.16 | $0.13 | $0.56 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $583.6M | $519.4M | $631.2M | $940M | $994.3M | |
| Total Assets | $4.5B | $4.3B | $5.3B | $5.5B | $5.9B | |
| Current Liabilities | $423.7M | $419.6M | $502.8M | $505.7M | $1B | |
| Total Liabilities | $3B | $2.7B | $3.1B | $2.9B | $2.8B | |
| Total Equity | $1.5B | $1.6B | $2.1B | $2.6B | $3.1B | |
| Total Debt | $1.3B | $1.2B | $1.5B | $1.2B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $265.4M | $574.6M | $683M | $146.9M | $115.8M | |
| Cash From Investing | -$286.2M | -$377.2M | -$404.3M | -$100.6M | -$106.9M | |
| Cash From Financing | -$19.8M | -$1.9M | -$114.9M | -$88.1M | -$22M | |
| Free Cash Flow | -$23M | $244.2M | $259.6M | $49M | $4.1M | |
Hudbay Minerals, Inc. operates as a mining company. The firm engages in the production of copper concentrate, molybdenum concentrate and zinc metal. It focuses on the discovery, production and marketing of base and precious metals. The company was founded on January 16, 1996 and is headquartered in Toronto, Canada.
In the current month, HBM has received 10 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HBM average analyst price target in the past 3 months is $22.2000.
According to analysts, the consensus estimate is that Hudbay Minerals, Inc. share price will rise to $22.2000 per share over the next 12 months.
Analysts are divided on their view about Hudbay Minerals, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hudbay Minerals, Inc. is a Sell and believe this share price will drop from its current level to $21.5000.
The price target for Hudbay Minerals, Inc. over the next 1-year time period is forecast to be $22.2000 according to 10 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Hudbay Minerals, Inc. is a Buy. 10 of 10 analysts rate the stock a Buy at this time.
You can purchase shares of Hudbay Minerals, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hudbay Minerals, Inc. shares.
Hudbay Minerals, Inc. was last trading at $19.8600 per share. This represents the most recent stock quote for Hudbay Minerals, Inc.. Yesterday, Hudbay Minerals, Inc. closed at $19.8600 per share.
In order to purchase Hudbay Minerals, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.